The U.S. Food and Drug Administration on Wednesday approved TG Therapeutics Inc's TGTX.O drug for patients with relapsing forms of multiple sclerosis, pitting it against rivals from Roche ROG.S and Novartis NOVN.S, according to the health regulator's website.
https://www.nasdaq.com/articles/u.s.-fda-approves-tg-therapeutics-multiple-sclerosis-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.